Sub services

WRITERS AND EDITORS

Clinical Trial Audit and Monitoring Services

Our well-trained clinical research associates (CRAs) are highly trained professionals who ensure the integrity of the study and committed to excellence

Efficient monitoring of Clinical sites from Site Qualification to Report generation

Pepgra offers risk-based high-quality services in clinical trial monitoring, that ensures scientific excellence and data integrity across operational centres and regional hubs. Our in-house project management and operations team travel across the globe to support the project team, by leveraging local knowledge of the regulatory environment. Our clinical research associate team, who are aware of local laws, regulations and guidelines will work with you on-site as part of your team – they bring the commitment, passion and motivation to maximize the potential of everyone.

We offer a remote monitoring solution that can be delivered to our customers, which would reduce the frequency of on-site visits and enhance data quality. Our experts ensure that there is perfect coordination among clinical research associates, project managers, sponsors, and clinical trial sites.

Pepgra CRO rigorously scrutinizes its CMD services and projects in terms of the teams involved in them and resources used with the aim to ensure details of every project are strictly kept within its operational zone. By providing our clients with the most sophisticated services in CDM, we have transcended the conventional model. We continue to strive to take CMD services to even greater heights.

Comprehensive Clinical Trial Monitoring Solutions

  • Site selection and feasibility
  • Development of recruitment criteria (Inclusion and exclusion criteria) with proper consent
  • Managing patient recruitment
  • Inbuild quality assurance mechanisms
  • Assurance of good clinical practice (GCP) including training and motivational visits
  • Communication with sites
  • Customizable training based on the requirements
  • Initiation, interim monitoring, and study closure visits
  • Managing of local ethics review process
  • Study-specific training to site personnel

Clinical Trial Audit and Monitoring Services

Pepgra, a leading contract research organization (CRO) brings together experts in scientific, clinical, regulatory, statistical – put them to work for you to design your protocol and execute the trials.

Clinical Study design and protocols that balance the interests of multiple stakeholders

To estimate the magnitude of treatment effect or difference in the treatment effect, there is a need for a good trial design approach that allows the treatment effect to be sorted out from person-to-person variability in response. With a better-informed protocol, clinical trials can able to answer the objectives of the study, while reducing the confounding and bias in estimating treatment effects thereby reduces the overall time, costs and richer evidence of value to stakeholders

At Pepgra CRO, we are sensitive to the need of balancing scientific, regulatory and logistical concerns to design and plan a successful clinical investigation. Our team has experience in developing study design for both new drugs and medical device despite the risk stratification (or class) of the device. Our experts develop study design based on strong scientific evidence, and our study design experts regularly advise on the necessity, implications, and practicality of clinical study design factors.

Clinical Study Design Solutions

  • Clinical hypothesis consultation
  • Endpoint selection and confirmation
  • Statistical sample size calculation
  • Adaptive Design Clinical Trial (after initiation without undermining its validity and integrity)
  • Protocol writing and Protocol review
  • Randomization
  • Interim analysis
  • Resource planning
  • Cost estimation
  • Case report form (CRF) design
  • Literature review
  • Regulatory counsel
  • Sample size calculations and power analysis based on the published data or pre-existing study results
  • Literature search and summary
  • Randomization scheduling
  • Statistical and analysis planning for clinical trial protocols
  • Clinical trial Protocol writing and review
  • Preparation of draft IDE submission, including protocol summary
  • Participation in pre-IDE interactions with FDA
  • Submission of IDE to FDA
  • The breadth and depth of their combined expertise bring efficiency to the process—helping you realize the full potential of your study design protocol.

Global Regulatory & Clinical Writing Services

The Global Regulatory Medical Writing Unit at Pepgra delivers Clinical Study Protocols and Study Reports that are Scientifically accurate, Culturally Sensitive, fully Compliant with current regulations (ICH GCP guidelines), in a timely and Confidential manner.

End-to-End Regulatory Writing Services for Drugs and Medical Device

Pepgra, a Clinical Research Organisation (CRO), understand the importance of regulatory Medical Writing in Clinical Research that is written in a clear and precise manner which is easily understood by EMA (EU), FDA (USA), HPFB (Canada), PMDA (Canada), TGA (Australia), MCC (South Africa), ASIAN (Hong Kong), GCC, CIS (Russia) and any other reviewers. It is risky to submit a poorly written protocol which leads to a huge loss of time and money. Further, delays and additional revisions can have significant cost implications. However, our qualified regulatory medical writing services help you in composing well-written regulatory documents and ensure that your dossier is reviewed, edited and proofread properly that helps you save time and money. Pepgra regulatory medical writers work closely with your statistical, medical regulatory and data management team to deliver the meticulously accurate document to the highest ethical and scientific industry standards.

Regulatory & Clinical research writing experts have the capabilities and skills to prepare regulatory submission documents required to seek approval for drugs (new drugs application / abbreviated New Drug Application – ANDA or), devices and nutraceuticals (for health claims). The regulatory Medical Writing Solutions we offer include regulatory compliance solutions in preparing essential documents for clinical trial submissions such as investigator brochures (IBs), protocols, dossier development including common technical documents (CTDs), eCTD modules, periodic safety update reports (PSURs), development safety update reports (DSURs), annual safety reports (ASRs),

clinical study reports (CSRs), documents related to pharmacovigilance like risk management plans (RMPs), periodic safety update reports (PSURs) and other associated documents.

Pepgra Extensive Regulatory Experiences

Our comprehensive solutions for Pharmaceutical Companies

Full Dossier Development

  • Clinical Overview (eCTD Modules 2.5) including Literature Review
  • The Common Technical Document (CTD) Module 2.3: Quality Overall Summary (QOS) Module 2.4/2.6: Non-Clinical Overview [Pharmacology, Pharmacokinetics, Toxicology] / Summary
  • Module 2.5/2.7: Clinical Overview / Summary
  • Module 3, 4, & Module 5
  • Regulatory eCTD dossier preparation, publishing and submission
  • Clinical Expert Statements
  • IND/NDA, MAA, PMA, 510(k) preparation and submission in US FDA, EMA Europe, Canada, Asia Pacific, Gulf countries and semi-regulated countries
  • Briefing documents
  • Labeling and Core datasheet
  • Gap Analysis for Clinical part of the dossier
  • Pharmacovigilance documents such as Periodic Safety Update Reports

Pepgra CRO team has extensive knowledge of Pharmacokinetics, Pharmacodynamics, Pharmacogenomics who can facilitate trial life cycles by establishing efficient processes that reduce costs and deliver a rapid return on investment

For Medical Device

Premarket, CE-Mark Report, Clinical Data, Post-Market Studies

Pepgra has extensive experience in preparing following reports for Class, I (low risk), IIa, IIb, and III (high risk): For the Medical device, we are compliant with MEDDEV 2.7/1 Revision 4 guidelines to perform the clinical evaluation.

  • Clinical Evaluation Reports (CER) as part of the approval process allowing market access (CE-mark) for a medical device
  • Clinical Data – Safety and/or performance of information generated from Clinical use of a device in question or a similar device for which equivalence has been demonstrated
  • Equivalent Device Report – Similar technical, biological and clinical characteristics
  • In-depth literature search and appraisal of relevant publications along with drafting of the CEO by our qualified experts
  • IPremarket, CE-mark studies, post-market studies and registries

Pepgra Advantages to ensure the highest quality

    Our Expertise and Experience

  • Well-versed in working with various stakeholders like clinical operations, data management, biostatistics, medical and safety teams to deliver documents.
  • Experience in writing documents for various phases of clinical development including Phase I to Phase IV, post-marketing surveillance studies (PMS) and post-authorization safety studies (PASS)
  • Area of Regulatory Writing Experience include Medical Devices, Prescription Drugs (with extensive knowledge of pharmacokinetics, pharmacodynamics, pharmacogenomics), Over-the-counter Medicines, Veterinary medicines, Cosmetics, Biologics and Nutraceuticals
  • Complete understanding of the complex drug development process, including NCEs, generic, biologics and biosimilars
  • Knowledge of country-specific guidelines and norms.
  • Knowledge of GPP3, ICMJE, CONSORT/STROBE /PRISMA (as appropriate) and other applicable regulatory guidelines. Besides, ICH, ABPI (Association of the British Pharmaceutical Industry), and FDA guidelines, STRAD Standards for Reporting of Diagnostic Accuracy, MedDev Guidelines (European Standards)

    Our Experts (Regulatory Medical Writers):

  • Our geographically and professionally broad team of regulatory writers are qualified to the MSc, M.D., M.B.B.S., Pharm.D. or PhD level and possess extensive regulatory knowledge of industry guidelines located in 100+ countries.
  • Our regulatory medical writers have vast experience in writing and editing a wide range of clinical trial documentation involved in the regulatory process.
  • Our writers undergo regular training conducted by the AMWA (American Medical Writers Association) and the EMWA (European Medical Writers Association) and other recognized medical writing organization to keep their skills at the vanguard of the medical writing field.
  • Our translation team consists of native speakers with many years of experience in translating all documents necessary for the performance of clinical studies.

    Therapeutic Areas that we work

  • Vast experience in working across multiple therapeutic areas like Biochemistry, Diabetes, Gastrointestinal, Renal/Nephrology, Respiratory, Psychiatry, Rheumatology, Cardiovascular, Toxicology and Oncology

    Editing & Formatting:

  • Submission-ready documents in terms of technical information, language, format, and template used to prepare the document

    Our Quality Control & Assurance:

  • All our clinical development services are done in accordance with our SOPs compliant standards. All our regulatory documents undergo thorough scientific, medical, editorial, quality check and assurance to ensure that the clinical documents we produce are scientifically accurate.
  • The documents are prepared using sponsored-provided materials SOPs or pepgra suite of International Conference on Harmonization ICH-compliant templates and style guides. In either case, pepgra medical writing team ensures that the document we produce is of the highest quality in terms of scientific content, style and formatting.

    Delivery:

  • Timely delivery of the highest standard of quality
  • Culturally sensitive to the locale and competitive price

Our regulatory medical writers hold vast experience in handling a wide range of therapeutic areas and all phases of development that are sound from both a scientific and regulatory perspective.

Clinical Biostatistics & Statistical Programming

Pepgra provides direction to sponsors in the design, conduct, analysis, and evaluation of clinical trials.

Extensive research, clinical and regulatory biostatistics services to meet your individual research needs

Pepgra offers regulatory biostatistical analysis as per the principles outlined in the International Conference on Harmonization (ICH) E9 guidelines. We bring a deep understanding of the science of disease and compounds, thereby provide comprehensive planning assistance

We offer you the benefits of the most sophisticated technology in biostatistics. Our regulatory statisticians with a comprehensive understanding of time-tested and latest statistical methods give you an accurate evaluation of scientific data. They design and conduct experiments, analyze the date and interpret the results in the way the results best meet the people’s requirements. Our regulatory biostatisticians and programming teamwork as an integral part of the assessment process, thereby it assures that the statistical principles outlined in the ICH E9 adhere when generating clinical Trial data that intended to be submitted to regulatory authorities. Adhering to these guidelines are mandatory if the product has European (USA and Japan as well) Wide marketing especially for centralized and mutual recognition submission.

Our research team is continuously engaged in studying following the latest research on innovative methodologies and analytical techniques and collaborate with the biostatisticians in incorporating the new findings into our day to day services. We collaborate the best hands in the field of Health and medicine in providing efficient and cost-effective analysis related to neuroimaging and cardiac and pulmonary diseases, and many other clinical disciplines.

Pepgra CRO is committed to engaging in collaborative work with scientists across the world to enhance innovation and knowledge in public health, medicine, and biology. When necessary we meet face to face with our clients in cases where the project involves intricate specifications. We customize our services to meet your requirements and thus add value to the time and money you invest with us.

Comprehensive Biostatistical Solutions

    In terms of design and data collection

  • Our expertise has the capability to comment and describe the objective(s), design, methodology, statistical considerations, and organization of a trial from initial dose titration through post-marketing services
  • Real-time analysis presentation and scientifically sound interpretation and reporting of results
  • Randomization schedule creation.
  • A design technique for avoiding bias in clinical trials – blinding, randomization.
  • Trial design consideration – Parallel Group Design, cross over design, factorial,
  • Sample size estimation based on the study objective (safety, efficacy) and clearly highlight the null hypothesis, the alternative
  • We help the organization to collect primary and secondary documents from a wide range of source documents that includes hospital records, clinical and office charts, laboratory notes, memoranda, pharmacy dispensing records, subject diaries or evaluation checklists, copies or transcriptions certified, microfilm, x-day, and from any other documents.
  • Processes for targeted on-site monitoring and/or select sites.

    Analysis

  • Identify missing data, inconsistent data, outliers, unexpected lack of variability and deviation in the protocol
  • data transformation, estimation, confidence intervals, hypothesis testing, adjustment of significance and confidence interval
  • Examine data trends in terms of consistency, range and data variability within and across sites
  • Intent-to-treat (ITT) analysis, multiple primary variables, multiple treatment comparisons (e.g. Dunnett’s, Bonferroni Correction, Closed test procedures, single primary treatment comparison), treatment by centre interaction, dose response analysis, and magnitude effect,
  • Evaluate for significant or systematic errors in data collection and reporting on a site or across site or data integrity problems or potential data manipulation
  • Analyze characteristics of the sites and performance metrics,
  • Interim analysis to compare treatment arms with respect to efficacy or safety
  • Development of statistical analysis plan – a more technical and detailed elaboration fo the principle features stated in the protocol
  • Team is expertise in programming using SAS, R with expertise in clinical trial

Clinical Trial Patient Recruitment

We Streamline your recruitment strategy.

Pepgra patient recruitment team facilitate the recruitment process based on your protocol, pre-screening conditions and inclusion/exclusion criteria. You only pay for the successful enrolment of patients thereby eliminate risk for sites and sponsors. Our team of experts dedicates their time and energy to recruit patients for all clinical trials. We have the capability to recruit patient population across the globe and any therapeutic area.

Comprehensive Patient Recruitment Solutions

  • Cloud-based Patient identification and recruitment
  • SMS follow-up
  • Email Marketing Campaigns
  • Social media campaigns and targeting
  • SEO strategy
  • Team for Physician relationship
  • Patient sign up application – mobile friendly
  • Site reputation management.
  • Our system locates and provides access to ideal patient populations based on ICD-9 codes and positions your study site for success.

Regulatory Affairs

Regulatory affairs are another core area for clinical trials. Pharmaceutical firms need a constant update on in-and-out on country-specific regulatory and ethics requirements to keep compliant with ever-changing legislation.
A team regulatory affair at Pepgra CRO advice on legal and scientific restraints from a global perspective thereby help you achieve your goals

Pepgra CRO offers its clients high quality Clinical and Regulatory Expert Services. Our expertise in the regulatory services draws extensively on the latest research for helping you design and implement clinical, regulatory framework depending on their requirement. Our services in regulatory services have been widely appreciated by our clients from pharmaceutical and biotechnology industries.

Our experts in regulatory affairs from world’s top pharmaceutical firms pay the closest attention to providing support in developing new medicinal products, integrating regulatory principles, and drafting and submitting relevant reports to health authorities. Our project management team will gather all documents including informed consent forms, writing the information for volunteers, competing the online IRAS form and also obtain necessary documentation and specialist opinion for ethics submission. We guide our clients in planning and implementing post-marketing activities. We provide enhanced guidance to the start-ups in discovering, testing, manufacturing, and marketing of medicinal products and thus ensure that the products supplied to make a useful contribution to public health.

We offer our clients customized service assistance in decision making, planning and management, and availing and executing strategic training and projects. Our experts keep a close track of the periodic and interim changes in the legislation in various regions and guide our clients in incorporating necessary changes in the products and advise them on legal and scientific restrictions and requirements. We deem it as our responsibility to employ the expertise of our legal advisors to negotiate with health authorities to obtain marketing authorization for medicinal products. Pepgra CRO understands the value of offering their clients access to international biopharmaceutical industry experts. One of the primary objectives of Pepgra CRO is to enable their clients to achieve their enterprise goals through increased product value and cost-effectiveness. We value the time our clients invest with us and the trust they have in our services. Therefore, we always push ourselves to deliver the best to them in all our services

Comprehensive Regulatory affairs Solutions

    We serve you in
    • abbreviated new drug application (ANDA),
    • investigational medicinal dossier (IMPD),
    • CTA submissions,
    • paediatric investigation plan,
    • reformatting of dossiers,
    • financial analysis and agreement terms for licensing and acquisition,
    • health technology assessment,
    • medical and regulatory writing,
    • clinical development,
    • commercial assessment and valuation of biopharmaceutical assets,
    • health technology assessment,
    • pricing and market access,
    • product and portfolio decision making,
    • statistics and data analytics.

Clinical Data Management

In the market environment where there is continuous and increased monitoring on the part of regulatory authorities and considering the growth in the intricacy of clinical trial procedures, effective management of clinical data has emerged to be an aspect that is considered to be of an immense challenge to people concerned within clinical research

Considering these complexities and the basic nature of clinical trials, it essentially warrants the need for a system of clinical management that is state-of-the-art and extensive associated services that go a long way in simplifying the conduct, study design, compliance and management of discrepancy.

The process of gathering, storing and curating copious volumes of clinical data is deemed to be very intrinsic from the perspective of regulatory compliance. pepgra is a contract research organization that is engaged in full-service knowledge-based diverse activities and offers clinical data management solutions from Phase I through to post-marketing trials.

Pepgra offers clinical data management services that are specialized; clinical research organizations can stand to ensure that the quality of data is superior and also offers an assurance as to the integrity of the clinical data. Pepgra assures that the data that is being managed totally and absolutely complies with international standards with a view to ensure consistency within clinical data. In addition, our team also involves the use of data management best practices while adopting specific technologies that are latest to aid the process of clinical data management.

The process of gathering, storing and curating copious volumes of clinical data is deemed to be very intrinsic from the perspective of regulatory compliance. pepgra is a contract research organization that is engaged in full-service knowledge-based diverse activities and offers clinical data management solutions from Phase I through to post-marketing trials.

Pepgra offers clinical data management services that are specialized; clinical research organizations can stand to ensure that the quality of data is superior and also offers an assurance as to the integrity of the clinical data. Pepgra assures that the data that is being managed totally and absolutely complies with international standards with a view to ensure consistency within clinical data. In addition, our team also involves the use of data management best practices while adopting specific technologies that are latest to aid the process of clinical data management

Comprehensive clinical data management Solutions

    The services that are being offered by Pepgra CRO encompasses;

  • developing CRF /eCRF papers,
  • Double-key data entry
  • CRF printing and distribution, design and
  • set up of the clinical database,
  • developing a clinical database that can be delivered with the help of CDISC SDTM standard.
  • In addition, definitions of data are provided in a manner that ascribes to the specifications as laid down by CDISC CRT-DD.
  • Effective management of data that has been transferred electronically (central readers, central labs).
  • Data validation
  • SAE reconciliation
  • Query generation & resolution
  • Integration of transferred data into clinical database
  • SAS datasets
  • Data management system
  • Services also include data that is transferred being integrated with the clinical database, transferred data being reconciled against CRF data, validation of data and generating query and resolution.
  • Our team of global clinical data management experts are committed to holding a process driven approach thereby develop a truly customized approach. We offer technology expertise in running clinical trials on EDC, CTMS, eTMF platforms and importing data from various devices

Clinical Trial Audit and Monitoring Services

Pepgra has extensive experience in preparing PMS report. Our PMS experts adhere to the guidelines such as the European Medicines Agency (EMA), FDA, or other local country guidelines.

End-to-End post-market surveillance

In recent years, emphasis in legislation on post-market clinical data is becoming increasingly more prevalent. Thus, regulatory agencies have compelled the need for a feedback system specifically to provide early warning of quality problems and for input into corrective and preventive action processes for the manufacturers.

Pepgra CRO helps in advancing public health by detecting and assessing safety indications from available data sources using evidence-based techniques and recommends appropriate regulatory actions such as changes in labelling, Risk Evaluation and Mitigation Strategies and communication of relevant safety information. Pepgra CRO with its vast knowledge of pharma industry and impressive in-house capabilities offers their clients high quality and cost-effective services in post-marketing surveillance. Our post-marketing surveillance experts with strong educational background and experience in clinical training offer you effective solutions to mitigate adverse effects of drugs and medical devices. We leverage our state-of-the-art technological infrastructure to transfer the benefits of latest advancements in PMS to our clients.

We collaborate with expert PMS analysts and systems around the world to provide the best of PMS services to our clients. Our scrupulous adherence to global guidelines and best practices in documentation has enabled us to win distinct appreciation from our clients for consistency and professionalism. Our team has well-versed understanding of various guidelines including MEDDEV, and EN ISO. We understand the repercussions of administering drugs or medical devices that are likely to cause serious adverse effects in the patients.

Pepgra CRO organizational philosophy shows zero tolerance to even marginal fluctuations when it comes to maintenance of safety standards and effectiveness of the drug or medical device. Our service in the way of end-to-end complaint management system is very helpful to our clients in addressing issues related to patient outcomes in a cost-effective way. We ensure that all our PMS services conform to GPSP and GVP standards.

At Pepgra CRO, PMS experts undergo continuous scientific training to gain insights into the latest processes, procedures and technological advancements that impact the quality and delivery of PMS services. In addition, Pepgra CRO’s customized learning and development programs prepare our expert team to meet the challenges of technically complex PMS processes. Our team of consultants possess excellent knowledge of engineering, quality assurance, product engineering besides considerable regulatory compliance experience. We make the optimal use of global PMS template in offering PMS services to our clients. Our global network helps us offer to provide services of international standards at reasonable prices. Our blend of highly qualified and trained PMS specialists and sophisticated technological prowess is enabling us to provide effective PMS suggestions and recommendations to our clients.

Comprehensive Post-market surveillance

    Our services include

  • Case/Exposure Management
  • Adverse Event Follow Up
  • Medical Monitoring & Reporting Services
  • Post-marketing Literature Surveillance
  • Pre-Post Marketing Clinical Studies
  • compliant intake,
  • registration and investigation,
  • product surveillance,
  • complaint management,
  • technical services,
  • regulatory assessment,
  • diagnostic reporting,
  • organizing training,
  • complaint analysis,
  • content development and packaging,
  • product analysis,
  • contact centre for patient assistance and
  • physician notification, management
  • trending and analytics, leadership management, and outreach programs to increase patient pool.
  • Imparting training (store, stream, deliver content) as a service
  • Key Opinion Leader Management as a service
  • Content development and packaging
  • Unique outreach platforms to increase patient pool

Clinical Technology & Process

Due to an enormous degree of technological innovation in the healthcare system, today’s hospitals have become technologically sophisticated centres of healthcare delivery and thus demand technologically competent staff

Pepgra CRO offers clinical technologists with the technology side of clinical operations where they play an important role in assisting the hospitals or physicians by providing the technological support they require.

Pepgra CRO offers you the state of the art services in clinical technology. Our long experience with Electronic Data Capture technology in clinical procedures has enabled us to become one of the frontrunners in clinical technology services industry. We serve biotechnology, medical device, and pharmaceutical companies with technological support to manage their clinical R & D trials, technology infrastructure, and business operations.

Our global delivery model provides native language support and multilingual support to serve your patients, investigators, site staff, and supervisors. We offer complete assistance in site assessment and internet service provider connectivity. We evaluate technological infrastructure of the site and ramp-up requirements that would facilitate access to clinical applications and facilities. With our in-house expertise, we ensure that your sites are equipped with custom software images. We provide the necessary hardware support besides solutions for breakage, warranty repairs, and sophisticated remote diagnosis devices to monitor the end-users in the trial.

Our close-out process has been so designed that the data delivered is highly secure and in time. Besides, the process has provision for quality assurance and confirmation from the investigators once they have received and reviewed it. Having understood the varying needs and preferences of our clients, we provide maximum flexibility and scalability to realize their enterprise goals. We leverage our in-house expertise in Life Sciences Support Service to provide the most cost-effective and high-quality service to our clients. Our assistance to pharmaceutical companies in upgrading their IT infrastructure has helped us understand the interaction between the pharmaceutical industry and IT in the global organization and upscale our service offering for Life Sciences Clients.

Our clinical technology training module, which is offered by our experts in-person or through the web, intends to develop your software skills and business process knowledge to help you obtain more accurate and comprehensive clinical trial data. We recognize the challenges before the sponsors and service providers. We are committed to establishing and developing sustainable contracts and working towards achieving a strong partnership with our clients.

Comprehensive Clinical Technology & Process Solutions

    Our services include

  • Development of Custom software images.
  • Hardware support besides solutions for breakage, warranty repairs, and sophisticated remote diagnosis devices to monitor the end-users in the trial.
  • upgrading their IT infrastructure
  • complete assistance in site assessment and internet service provider connectivity
  • Other services include biostatistical services overview, drug strategy analysis, drug accountability and reconciliation overview, interactive response technology, investigator selection, trial site initiation, patient recruitment, application support, provisioning, site assessment, data integration, electronic clinical outcome assessments, electronic clinical outcome assessments features and electronic clinical outcome assessment reporting